Adult Motion Sickness Pharmacologic Options
Pharmacologic prevention is most effective when taken before exposure because oral absorption may be impaired after symptom onset. (cdc.gov) Common preventive drug classes include antimuscarinics (scopolamine), H1 antihistamines (dimenhydrinate, meclizine, promethazine), and selected sympathomimetics in specialized settings, though sympathomimetics are not available in the adult traveler setting described in CDC guidance. (cdc.gov)
Medication Selection Algorithm
For short-term motion exposure (≤6 hours), mild to moderate stimuli favor meclizine or dimenhydrinate. (cdc.gov) For short-term intense stimuli, promethazine is favored. (cdc.gov) For longer-term motion exposure (>6 hours), mild stimuli favor meclizine or dimenhydrinate. (cdc.gov) For longer-term moderate to intense stimuli, a scopolamine transdermal patch is favored. (cdc.gov)
Dosing Regimens by Medication
Scopolamine (antimuscarinic)
- Transdermal scopolamine patch (1 mg system; e.g., Transderm Scōp): apply 1 patch behind one ear to a hairless area at least 4 hours before antiemetic effect is required. (accessdata.fda.gov)
- Duration: scopolamine transdermal patch delivers medication for up to 72 hours. (cdc.gov)
- Oral scopolamine (non-US example): 0.3–0.6 mg with onset ~4 hours and duration ~4 hours. (cdc.gov)
- IM scopolamine (non-US example): 0.1–0.2 mg with onset ~4 hours and duration ~4 hours. (cdc.gov)
Promethazine (H1 antihistamine)
- Oral promethazine: 25–50 mg with onset ~2 hours and duration ~15 hours. (cdc.gov)
- IM promethazine: 25 mg with onset ~1/4 hour and duration ~15 hours. (cdc.gov)
- Promethazine suppository: 25 mg with onset ~1 hour and duration ~15 hours. (cdc.gov)
Dimenhydrinate (H1 antihistamine)
- Oral dimenhydrinate (OTC example): 50–100 mg with onset ~2 hours and duration ~8 hours. (cdc.gov)
- Dimenhydrinate injection (example): 50 mg with onset ~1/4 hour and duration ~8 hours. (cdc.gov)
Meclizine (H1 antihistamine)
- Oral meclizine: 25–50 mg with onset ~2 hours and duration ~8 hours. (cdc.gov)
- OTC chewable meclizine (example): 25–50 mg with onset ~2 hours and duration ~8–24 hours. (cdc.gov)
Timing of Administration Relative to Exposure
Oral medications should be taken in sufficient time to allow absorption because once initial symptoms begin, gastric stasis may prevent absorption. (cdc.gov) The CDC onset-times table indicates typical onset windows of ~1–4 hours depending on the agent and route. (cdc.gov) A scopolamine patch is applied at least 4 hours before antiemetic effect is required. (accessdata.fda.gov)
Monotherapy Versus Combination Therapy
Medication selection is typically performed as single-agent prophylaxis based on exposure duration and stimulus intensity. (cdc.gov) Combination regimens that include highly effective stimulant approaches are not available in the traveler setting described in CDC guidance. (cdc.gov)
Important Contraindications and Practical Nuances
Scopolamine should not be used in travelers with glaucoma or who are at risk of prostatic urinary retention. (cdc.gov) The scopolamine patch should never be cut because cutting disrupts the mechanism of drug release. (cdc.gov) Common adverse effects of anti-motion-sickness drugs include drowsiness/sedation, dry mouth, and dry eyes. (cdc.gov) Promethazine is described as the most sedating among common agents, while scopolamine is described as slightly less sedating than dimenhydrinate or meclizine. (cdc.gov)
Common Pitfalls to Avoid
Delay of dosing until after symptom onset reduces effectiveness because gastric stasis may impair absorption. (cdc.gov) Dose manipulation of the scopolamine patch by cutting is avoided because it disrupts release. (cdc.gov)
Therapy Goals and Expected Duration of Protection
The expected duration of protection depends on the agent and route, ranging from approximately 4 hours for non-US oral or IM scopolamine examples to approximately 72 hours for the scopolamine transdermal patch. (cdc.gov) For oral H1 antihistamine options, typical durations in the CDC adult dosing table are approximately 8 hours for dimenhydrinate and meclizine, and approximately 15 hours for oral promethazine. (cdc.gov)